Clinical trials
Arthritis, Psoriatic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
592 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 10 |
| 2006 | 11 |
| 2007 | 13 |
| 2008 | 9 |
| 2009 | 7 |
| 2010 | 15 |
| 2011 | 13 |
| 2012 | 13 |
| 2013 | 28 |
| 2014 | 22 |
| 2015 | 33 |
| 2016 | 24 |
| 2017 | 34 |
| 2018 | 28 |
| 2019 | 49 |
| 2020 | 37 |
| 2021 | 45 |
| 2022 | 39 |
| 2023 | 31 |
| 2024 | 35 |
| 2025 | 41 |
| 2026 | 33 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 336 |
| Recruiting | 82 |
| Unknown status | 58 |
| Active, not recruiting | 34 |
| Terminated | 30 |
| Not yet recruiting | 25 |
| Withdrawn | 18 |
| Enrolling by invitation | 6 |
| Suspended | 2 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 27 |
| AbbVie | 25 |
| Amgen | 20 |
| Pfizer | 20 |
| Janssen Research & Development, LLC | 19 |
| UCB Biopharma SRL | 12 |
| Bristol-Myers Squibb | 11 |
| AbbVie (prior sponsor, Abbott) | 9 |
| University of Oxford | 9 |
| Chinese University of Hong Kong | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Psoriatic | 592 |
| Arthritis, Rheumatoid | 180 |
| Psoriasis | 127 |
| Spondylitis, Ankylosing | 100 |
| Arthritis | 56 |
| Crohn Disease | 46 |
| Spondylarthritis | 39 |
| Colitis, Ulcerative | 34 |
| Axial Spondyloarthritis | 31 |
| Lupus Erythematosus, Systemic | 25 |
Trials
Showing 1 to 25 of 592. Each trial links to its page on Pharma Observatory.
492 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.